Vivos Completes Planned Dosing Schedule for Feline Sarcoma Program
12 janv. 2018 11h54 HE
|
Vivos Inc.
Richland, WA, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has completed its planned dosing schedule to determine the effectiveness of using the Company’s...